Cannabis-like medicine and brain scans in young adults
Treatments studied
Part of Mental health clinical trials.
This study looks at how a single dose of a cannabis-like medicine (dronabinol) affects the brain using brain scans (MRI and PET). It might help us learn more about how cannabis affects young adults who use it occasionally, which could guide future treatments for conditions like depression or chronic pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 21 years old
- Your body mass index (BMI) is between 18.5 and 30
- You have used cannabis at least 10 times in your life and at least once in the past 3 months, but NOT daily
- You are medically and neurologically healthy (no major health issues)
- You do not have any metal in your body that would make an MRI unsafe
- You are not pregnant or breastfeeding, and you don't use heavy nicotine products
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a natural compound found in plants, called myrcene, affects the body's response to THC (the active ingredient in cannabis). It may help us understand how these substances work together.
This early-phase study uses brain scans to study cannabis use disorder and looks at whether a treatment approach is suitable for people who use cannabis every day. It may help researchers understand brain changes related to quitting and recovery.
This study looks at the brains of teenagers who use cannabis using an MRI scanner. It aims to understand how cannabis affects the developing brain, which might help improve treatment options.
This study looks at how cannabis affects your brain's reward system using MRI scans. It aims to understand why some people develop cannabis use disorder, which may lead to better treatments.
This Phase 1 study tests how THC (the main active ingredient in cannabis) affects healthy adults, and whether effects differ by gender. It’s designed to learn about short-term body and brain responses to THC.
This early study measures how a THC dose (by mouth or vaporized form) moves through the body and how it affects the body’s responses. It mainly looks at safety and how THC behaves in older adults, including people who have used cannabis before.
Hear when a new Cannabis Use trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.